A new study points out the risk of nonsteroidal anti-inflammatory drug (NSAID) use in patients who have had a myocardial infarction (MI) suggesting that even brief use increases the risk for death and recurrent MI.
The FDA has approved linagliptin for the treatment of type 2 diabetes in adults.
The FDA has approved two new drugs for the treatment of hepatitis C the first new drugs to be approved in years.
Niacin may not be effective in preventing cardiovascular disease.
Osteoporosis is a highly prevalent metabolic bone disease that affects both men and woman at risk of bone demineralization.
Erectile dysfunction (ED) is the most common sexual problem in men, affecting up to one-third at some point in their lives.
